Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
About Index
Index
By TNW
Log in
Register
Autolus Ltd.
1643
Autolus Ltd.
Health Care
Medical
Pharmaceuticals
Autolus is a private biopharmaceutical company, focused on the development and commercialisation of engineered Tcell immunotherapy products with extreme efficacy in the treatment of lifethreatening cancers..
Suggest edits
Type
B2b
Founded
2014
Raised
$285.6M
Follow us
Also headquartered in London
Blockchain
Reuters
Springwise
BBC
Revolut
DeepMind
Volkswagen
HSBC
Cambridge Analytica
Ubuntu
Companies in the same industry
IDP Pharma
AgentBalance
Prexton Therapeutics SA
Polestar Nutraceuticals
SynbiCITE
Apikos Pharma
Olema Pharmaceuticals
American Injectables
Mycodev Group
Sirenas Marine Discovery
Alexa global traffic share
Overview
Funding
3
Add info
Latest funding
Show all
$150,000,000
IPO - 2018
$80,000,000
Venture capital (Series C) - 2017
Cormorant Asset Management
Nextech Invest
Arix Bioscience
+2
Team Size
10+
Employees
I work here
Location
London
,
United Kingdom
Headquarters
Explore London
Pulse 2.0
Autolus Therapeutics (AUTL) Stock: Why The Price Surged Today
Pulse 2.0
Autolus Therapeutics (AUTL) Stock: 35.47% Increase Explanation
the home of AI info
Autolus Therapeutics plc (AUTL)'s Financial Results Comparing With Minerva Neurosciences Inc ...
$150,000,000
IPO
PE HUB
Autolus goes public
Stock markets
Privacy
PE HUB
Autolus sets IPO pricing terms
Stock markets
Privacy
PE HUB
Autolus taps Oakley as SVP and CFO
PE HUB
UK biotech firm Autolus joins CAR-T rush with Nasdaq IPO filing: Reuters
Health
